James Graham Brown Cancer Center Clinical Trials
Sponsors / James Graham Brown Cancer Center
James Graham Brown Cancer Center appears as lead sponsor on 36 trial records in ClinicalTrials.gov. The portfolio currently includes 3 recruiting studies, 2 active non-recruiting studies, and 18 completed studies. 11 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints, efficacy or futility findings. Cumulative planned enrollment across all listed trials is 9,101 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
36
Total Trials
3
Recruiting
2
Other Active
18
Completed
11
Terminated / Withdrawn
9,101
Total Enrollment
Termination reasons: Recruitment55% · Funding27% · Efficacy9% · PI/or_Site9%
Recent Terminations
- Multiple Myeloma"Principal Investigator left institution-study not continued"
- Vertebral Metastasis"Unable to enroll"
- Metastatic Melanoma"low enrollment r/t requirement of prior treatment with denileukin diftitox"
- Non Small Cell Lung Cancer"slow accrual"
- Non-small Cell Lung Cancer"slow accrual"
- Heparin-Induced Thrombocytopenia"study terminated due to low accrual"
- Carcinoma, Non-Small Cell Lung"Interim analysis revealed that only 1 patient had a partial response."
- NCT00375804 Stopped Jun 2010Endometrial Cancer"Funding and logistical difficuties resulted in the withdrawl of the study."
- Leukemia, Lymphocytic, Chronic"terminated due to lack of accrual"
- NCT00268151 Phase PHASE1Carcinoma, Non-Small Cell Lung"Study was terminated due to lack of funding."
Active Trials (2 total)
- Metastatic Breast Cancer PHASE2NCT04990921
- NCT00682032
- Glioblastoma PHASE1/PHASE2NCT01985087
- Metastatic Melanoma PHASE2NCT00553618
- Melanoma PHASE1/PHASE2NCT01638676